Bradley J. Sumrow

Bradley J. Sumrow, MD has a diverse work experience. Bradley J. is currently an Executive Medical Director at Mersana Therapeutics, a role they began in March 2023. Previously, they held the same position at Calithera Biosciences from December 2021 to January 2023.

Prior to their executive roles, Dr. Sumrow worked at MacroGenics, Inc. from November 2015 to December 2021. During their time there, they held various positions including Senior Director of Clinical Research, Director of Clinical Research, Medical Director of Clinical Development & Pharmacovigilance, and Product Safety Scientist.

Before joining MacroGenics, Inc., Dr. Sumrow worked at Dendreon as a Pharmacovigilance Scientist from March 2014 to June 2015.

Earlier in their career, Dr. Sumrow gained experience at UNC Hospitals as a Resident Physician in Anesthesiology from June 2010 to January 2014. Bradley J. received comprehensive training in perioperative care, including various ICU experiences and exposure to complex surgical procedures.

Dr. Sumrow also has experience as an MRI Technologist at WakeMed from August 2005 to May 2006 and as an Information Technology Support Specialist at UNC Kenan-Flagler from July 2002 to June 2004. In the latter role, they provided technology support to faculty, instructors, and students, with responsibilities including troubleshooting and multimedia support.

Overall, Dr. Sumrow's work experience showcases their expertise in clinical research, medical leadership, and perioperative care.

Dr. Bradley J. Sumrow obtained their MD degree in Medicine from the University of North Carolina at Chapel Hill School of Medicine from 2006 to 2010. Prior to that, they completed their undergraduate studies at the same institution, receiving a BS degree in Radiologic Science from 2001 to 2005. Dr. Sumrow also holds a Certificate in Mathematics from N.C. Governor's School East, which they earned in the year 2000. In addition to their academic qualifications, they obtained a North Carolina Medical License (Full) from the North Carolina Medical Board in 2012.